NCT01302808 2021-01-20Romidepsin and Erlotinib Hydrochloride in Treating Patients With Stage III or Stage IV Non-Small Cell Lung CancerUniversity of Texas Southwestern Medical CenterPhase 1 Completed17 enrolled 12 charts